These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14745376)

  • 1. Conference report - global vaccines - what are the challenges? Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.
    Armandola E
    MedGenMed; 2003 Dec; 5(4):29. PubMed ID: 14745376
    [No Abstract]   [Full Text] [Related]  

  • 2. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public health. Progress toward rotavirus vaccines.
    Parashar UD; Glass RI
    Science; 2006 May; 312(5775):851-2. PubMed ID: 16690845
    [No Abstract]   [Full Text] [Related]  

  • 6. Rotavirus disease and vaccines in India: a tremendous public health opportunity.
    Tate JE; Arora R; Bhan MK; Yewale V; Parashar UD; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():vii-xii. PubMed ID: 25091690
    [No Abstract]   [Full Text] [Related]  

  • 7. Lessons from the US rotavirus vaccination program.
    Glass RI; Patel M; Parashar U
    JAMA; 2011 Oct; 306(15):1701-2. PubMed ID: 22009102
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rotavirus vaccination in Europe in 2010].
    Grimprel E
    Bull Acad Natl Med; 2010 Nov; 194(8):1451-62; discussion 1462-4. PubMed ID: 22046709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization.
    Christie CD; Duncan ND; Thame KA; Onorato MT; Smith HD; Malcolm LG; Itzler RF; Dinubile MJ; Heaton PM
    Pediatrics; 2010 Dec; 126(6):e1499-506. PubMed ID: 21115586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of immunisation against rotavirus.
    Marlow RD; Finn A
    Arch Dis Child; 2012 Aug; 97(8):736-40. PubMed ID: 22611059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global impact of rotavirus vaccines.
    Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
    Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccine: a welcome addition to the immunisation schedule in the UK.
    Iturriza-Gómara M; Cunliffe N
    BMJ; 2013 Apr; 346():f2347. PubMed ID: 23587749
    [No Abstract]   [Full Text] [Related]  

  • 14. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccines at the threshold of implementation in India.
    Tate JE; Arora R; Kang G; Parashar UD
    Natl Med J India; 2014; 27(5):245-8. PubMed ID: 26037421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey.
    Smith PJ; Schwartz B; Mokdad A; Bloch AB; McCauley M; Murphy TV
    Public Health Rep; 2003; 118(2):134-43. PubMed ID: 12690067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom.
    Lorgelly PK; Joshi D; Iturriza Gómara M; Gray J; Mugford M
    Epidemiol Infect; 2008 Jan; 136(1):44-55. PubMed ID: 17335631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from global data for use of rotavirus vaccines in India.
    Rao TS; Arora R; Khera A; Tate JE; Parashar U; Kang G;
    Vaccine; 2014 Aug; 32 Suppl 1():A171-8. PubMed ID: 25091672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus: a new vaccine for the UK?
    Ramsay M
    Arch Dis Child; 1999 Aug; 81(2):101-2. PubMed ID: 10490510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.